Latest On STAAR Surgical Company (STAA):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-27 06:58 EST | News | I See Opportunity In STAAR Surgical | N/A |  |
| 2023-05-24 07:55 EST | News | STAAR Surgical: Revising To Hold Until Starting Valuations Improve (Rating Downgrade) | N/A | |
| 2023-05-04 04:22 EST | News | STAAR Surgical GAAP EPS of $0.05 beats by $0.06, revenue of $73.5M beats by $7.28M | N/A | |
| 2023-05-04 04:22 EST | News | STAAR Surgical Company (STAA) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-03 03:00 EST | News | STAAR Surgical Q1 2023 Earnings Preview | N/A | |
| 2023-03-29 18:40 EST | News | STAAR Surgical hires Warren Foust as COO | N/A | |
| 2023-03-15 02:12 EST | News | STAAR Surgical gains after reaffirming sales forecast | N/A | |
| 2023-03-06 19:35 EST | News | STAAR Surgical: A Good Business That (Almost) Anyone Can Run | N/A | |
| 2023-02-24 22:42 EST | News | STAAR Surgical Shines In Today's Uncertainties Due To Growing U.S. Revenue | N/A | |
| 2023-02-22 05:00 EST | News | STAAR Surgical falls as 2023 outlook disappoints | N/A | |
| 2023-02-22 05:00 EST | News | STAAR Surgical Company (STAA) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-21 16:24 EST | News | STAAR Surgical Non-GAAP EPS of $0.14 in-line, revenue of $64.04M misses by $0.4M | N/A | |
| 2023-02-21 02:32 EST | News | STAAR Surgical Q4 2022 Earnings Preview | N/A | |
| 2023-02-06 22:39 EST | News | STAAR Surgical downgraded to neutral at BTIG on Chinese economy uncertainty | N/A | |
| 2023-02-01 21:35 EST | News | STAAR Surgical Company: Getting Ahead Of Itself In 2023 | N/A | |
| 2023-01-09 20:49 EST | News | STAAR Surgical stock falls after guiding sales lower than estimates | N/A | |
| 2022-12-20 01:06 EST | News | Hot Stocks: STAA drops on CEO transition; HA falls; MESA working on UAL partnership; LVS non-gaming investment | N/A | |
| 2022-12-19 07:41 EST | News | STAAR Surgical CEO Caren Mason to retire | N/A | |
| 2022-11-28 18:27 EST | News | STAAR Surgical: Reasonable Risk-Reward For A High-Growth Company | N/A | |
| 2022-11-03 15:55 EST | News | STAAR Surgical Company (STAA) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-02 23:34 EST | News | STAAR Surgical Non-GAAP EPS of $0.38 beats by $0.17, revenue of $76.05M beats by $1.1M | N/A | |
| 2022-11-02 07:04 EST | News | STAAR Surgical Q3 2022 Earnings Preview | N/A | |
| 2022-09-20 22:39 EST | News | Keep Adding To STAAR Surgical Longs, Buy Thesis Remains | N/A | |
| 2022-08-11 16:04 EST | News | STAAR Surgical rises 15% on Q2 result beat | N/A | |
| 2022-08-10 23:57 EST | News | STAAR Surgical Non-GAAP EPS of $0.42 beats by $0.19, revenue of $81.1M beats by $0.98M | N/A | |
| 2022-08-10 23:56 EST | News | STAAR Surgical Company (STAA) CEO Caren Mason on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-10 06:03 EST | News | STAAR Surgical Q2 2022 Earnings Preview | N/A | |
| 2022-07-05 20:10 EST | News | STAAR Surgical: Hard Data Approach Justifies Long-Only Portfolio Allocation | N/A | |
| 2022-05-05 10:55 EST | News | STAAR Surgical Non-GAAP EPS of $0.29 beats by $0.14, revenue of $63.2M beats by $2.67M | N/A | |
| 2022-05-05 10:55 EST | News | STAAR Surgical Company's (STAA) CEO Caren Mason On Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-03 20:59 EST | News | STAAR Surgical Q1 2022 Earnings Preview | N/A | |
| 2022-04-10 04:08 EST | News | Is STAAR Surgical A Watchlist Contender? | N/A | |
| 2022-04-06 21:45 EST | News | STAAR Surgical's EVO Visian lens for myopia see 1st implant in US | N/A | |
| 2022-03-29 12:05 EST | News | STAAR Surgical stock soars 22% as FDA approves implantable lenses EVO for myopia | N/A | |
| 2022-03-19 07:47 EST | News | STAAR Surgical upped to Buy at BTIG on attractive valuation ahead of EVO launch | N/A | |
| 2022-02-24 19:56 EST | News | STAAR Surgical stock rises 12% as Q4 sales soar 28% Y/Y | N/A | |
| 2022-02-24 02:22 EST | News | STAAR Surgical Non-GAAP EPS of $0.19 beats by $0.03, revenue of $59M misses by $0.21M | N/A | |
| 2022-02-24 02:21 EST | News | STAAR Surgical Company's (STAA) CEO Caren Mason on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-23 06:27 EST | News | STAAR Surgical Q4 2021 Earnings Preview | N/A | |
| 2022-02-16 07:10 EST | News | STAAR Surgical: Drastically Overpriced | N/A | |
| 2022-01-10 09:11 EST | News | STAAR Surgical slips 2% on prelim FY21 revenue and earning update | N/A | |
| 2021-11-18 02:05 EST | News | STAAR Surgical: Tech Example Best Medical Devices Near-Term Buy As Seen By Market-Makers | N/A | |
| 2021-11-04 16:57 EST | News | STAAR Surgical Company (STAA) CEO Caren Mason on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-03 19:31 EST | News | STAAR Surgical EPS beats by $0.04, misses on revenue | N/A | |
| 2021-11-02 23:54 EST | News | STAAR Surgical Q3 2021 Earnings Preview | N/A | |
| 2021-09-03 02:57 EST | News | STAAR Surgical:Â Bright Future, But Hit The Pause Button | N/A | |
| 2021-08-05 13:53 EST | News | STAAR Surgical EPS beats by $0.09, beats on revenue | N/A | |
| 2021-08-05 13:53 EST | News | STAAR Surgical's (STAA) CEO Caren Mason on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-03 19:03 EST | News | STAAR Surgical Q2 2021 Earnings Preview | N/A | |
| 2021-07-22 02:39 EST | News | STAA, SCR, GMTX and ABCL among after-hours movers | N/A | |
About STAAR Surgical Company (STAA):
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
General
- Name STAAR Surgical Company
- Symbol STAA
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 575
- Last Split Factor1:2
- Last Split Date1992-05-18
- Fiscal Year EndJanuary
- IPO Date1983-07-15
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Supplies
- Web URLhttp://www.staar.com
View More
Valuation
- Trailing PE 763.83
- Forward PE 285.71
- Price/Sales (Trailing 12 Mt.) 27.56
- Price/Book (Most Recent Quarter) 22.18
- Enterprise Value Revenue 25.89
- Enterprise Value EBITDA 429.05
View More
Financials
- Most Recent Quarter 2021-01-31
- Profit Margin 4%
- Operating Margin 5%
- Return on Assets 2%
- Return on Equity 3%
- Revenue 163.46 million
- Earnings Per Share $0.12
- Revenue Per Share $3.58
- Gross Profit 119.56 million
- Quarterly Earnings Growth 18.3%
View More
Highlights
- Market Capitalization 4.27 billion
- EBITDA 10.99 million
- PE Ratio 97.97
- PEG Ratio -4.89
- Analyst Target Price $119
- Book Value Per Share $4.25
View More
Share Statistics
- Shares Outstanding 46.56 million
- Shares Float 33.85 million
- % Held by Insiders 117%
- % Held by Institutions 89.92%
- Shares Short 1.83 million
- Shares Short Prior Month 2.63 million
- Short Ratio 1.5
- Short % of Float 5%
- Short % of Shares Outstanding 4%
View More
Technicals
- Beta 0.96
- 52 Week High $128.23
- 52 Week Low $25.05
- 50 Day Moving Average 106.43
- 200 Day Moving Average 80.15
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
STAAR Surgical Company (STAA) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
STAAR Surgical Company (STAA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2021-01-31 | 2021-02-24 | $46 million | $0.14 | $0.10 | 43.59% |
| 2020-10-31 | 2020-11-04 | $N/A | $0.15 | $0.09 | 73.01% |
| 2020-07-31 | 2020-08-05 | $N/A | $0.03 | $0.03 | -11.76% |
| 2020-04-30 | 2020-05-06 | $35.19 million | $0.04 | $0.03 | 53.85% |
| 2020-01-31 | 2020-02-26 | $38.88 million | $0.12 | $0.10 | 20% |
| 2019-10-31 | 2019-10-31 | $38.88 million | $0.05 | $0.05 | 0% |
| 2019-07-31 | 2019-10-30 | $39.06 million | $0.12 | $0.08 | 44.06% |
| 2019-04-30 | 2019-05-01 | $39.66 million | $0.09 | $0.05 | 68.86% |
| 2019-01-31 | 2019-02-21 | $32.58 million | $0.07 | $0.02 | 200.43% |
| 2018-10-31 | 2018-11-01 | $31.19 million | $0.03 | ||
| 2018-07-31 | 2018-10-31 | $31.77 million | $0.07 | -$0.03 | 333.33% |
| 2018-04-30 | 2018-05-02 | $33.91 million | $0.04 | -$0.04 | 200% |
| 2018-01-31 | 2018-02-28 | $27.09 million | $0.02 | $0.01 | 100% |
| 2017-10-31 | 2017-11-08 | $24.85 million | $0.04 | $0.02 | 100% |
| 2017-07-31 | 2017-08-02 | $23.47 million | -$0.01 | -$0.01 | -100% |
| 2017-04-30 | 2017-05-03 | $21.94 million | -$0.04 | -$0.04 | 0% |
| 2017-01-31 | 2017-03-02 | $20.35 million | $0.02 | $0.02 | 0% |
| 2016-10-31 | 2016-11-03 | $22.14 million | -$0.02 | -$0.01 | -100% |
| 2016-07-31 | 2016-08-03 | $20.05 million | -$0.02 | -$0.04 | 42.86% |
| 2016-04-30 | 2016-05-11 | $20.97 million | -$0.01 | $0.02 | -159.88% |
| 2016-01-31 | 2016-03-02 | $20.86 million | $0.01 | -$0.02 | 150% |
| 2015-07-31 | 2015-10-28 | $18.66 million | -$0.04 | -$0.04 | 0% |
| 2015-04-30 | 2015-07-29 | $18.86 million | -$0.04 | -$0.03 | -33.33% |
| 2015-01-31 | 2015-02-25 | $16.57 million | -$0.07 | -$0.04 | -75% |
| 2014-10-31 | 2014-10-31 | $18.19 million | -$0.07 | ||
| 2014-07-31 | 2014-10-30 | $20.05 million | -$0.07 | $0.02 | -450% |
| 2014-04-30 | 2014-07-31 | $20.18 million | -$0.05 | $0.03 | -266.67% |
| 2014-01-31 | 2014-02-26 | $18.94 million | -$0.02 | $0.02 | -200% |
| 2013-10-31 | 2013-10-31 | $0.01 | |||
| 2013-07-31 | 2013-10-30 | $17.11 million | $0.01 | $0.02 | -50% |
| 2013-04-30 | 2013-05-01 | $18.16 million | $0.01 | $0.02 | -50% |
| 2013-01-31 | 2013-02-27 | $18 million | -$0.04 | $0.01 | -500% |
| 2012-10-31 | 2012-11-01 | $16.47 million | $-0.00 | ||
| 2012-07-31 | 2012-08-01 | $15.87 million | -$0.01 | $0.01 | -200% |
| 2012-04-30 | 2012-05-02 | $15.94 million | $0.01 | $0.01 | 0% |
| 2012-01-31 | 2012-03-06 | $15.51 million | $0.00 | $0.02 | -85% |
| 2011-07-31 | 2011-08-02 | $15.27 million | $0.02 | $0.01 | 100% |
| 2011-04-30 | 2011-05-03 | $16.27 million | $0.01 | ||
| 2011-01-31 | 2011-03-01 | $14.85 million | -$0.02 | $0.01 | -300% |
| 2010-10-31 | 2010-11-02 | $14.39 million | -$0.03 | $0.01 | -400% |
| 2010-07-31 | 2010-08-03 | $13.15 million | -$0.05 | $0.01 | -600% |
| 2010-04-30 | 2010-05-04 | $13.64 million | $0.10 | -$0.01 | 1100% |
| 2010-01-31 | 2010-03-02 | $13.78 million | -$0.27 | -$0.03 | -800% |
| 2009-10-31 | 2009-11-03 | $13.29 million | -$0.06 | -$0.03 | -100% |
| 2009-07-31 | 2009-08-03 | $12.46 million | -$0.04 | -$0.03 | -33.33% |
| 2009-04-30 | 2009-05-05 | $13.16 million | -$0.06 | -$0.06 | 0% |
| 2009-01-31 | 2009-03-16 | $12.16 million | -$0.12 | -$0.04 | -200% |
| 2008-07-31 | 2008-10-28 | $18.11 million | -$0.08 | -$0.06 | -33.33% |
| 2008-04-30 | 2008-05-06 | $20.67 million | -$0.17 | -$0.12 | -41.67% |
| 2008-01-31 | 2008-03-06 | $17.96 million | -$0.15 | -$0.10 | -50% |
| 2007-10-31 | 2007-10-31 | $15.89 million | -$0.13 | ||
| 2007-07-31 | 2007-08-06 | $13.63 million | -$0.16 | -$0.12 | -33.33% |
| 2007-04-30 | 2007-05-01 | $14.93 million | -$0.14 | -$0.11 | -27.27% |
| 2007-01-31 | 2007-03-14 | $14.92 million | -$0.16 | -$0.12 | -33.33% |
| 2006-10-31 | 2006-10-31 | $14.77 million | -$0.11 | ||
| 2006-07-31 | 2006-08-01 | $13.31 million | -$0.13 | -$0.12 | -8.33% |
| 2006-04-30 | 2006-05-02 | $14.73 million | -$0.12 | -$0.13 | 7.69% |
| 2006-01-31 | 2006-03-02 | $13.47 million | -$0.14 | -$0.09 | -55.56% |
| 2005-10-31 | 2005-11-03 | $12.07 million | -$0.13 | -$0.07 | -85.71% |
| 2005-04-30 | 2005-07-28 | $13.91 million | -$0.09 | -$0.08 | -12.5% |
| 2005-01-31 | 2005-03-09 | $13.68 million | -$0.19 | -$0.15 | -26.67% |
| 2004-10-31 | 2004-11-02 | $13.95 million | -$0.11 | -$0.17 | 35.29% |
| 2004-04-30 | 2004-07-29 | $12.02 million | -$0.18 | -$0.07 | -157.14% |
| 2004-01-31 | 2004-03-03 | $13.57 million | -$0.19 | -$0.08 | -137.5% |
| 2003-10-31 | 2003-10-31 | $12.75 million | -$0.15 | ||
| 2003-07-31 | 2003-10-30 | $11.93 million | -$0.13 | -$0.08 | -62.5% |
| 2003-04-30 | 2003-05-01 | $12.95 million | -$0.04 | -$0.04 | 0% |
| 2003-01-31 | 2003-02-27 | $12.83 million | -$0.05 | -$0.07 | 28.57% |
| 2002-07-31 | 2002-10-31 | $11.2 million | -$0.10 | -$0.07 | -42.86% |
| 2002-04-30 | 2002-07-25 | $12.09 million | -$0.18 | -$0.08 | -125% |
| 2002-01-31 | 2002-03-06 | $11.73 million | -$0.03 | -$0.02 | -50% |
| 2001-07-31 | 2001-08-09 | $12.15 million | -$0.01 | -$0.02 | 50% |
| 2001-04-30 | 2001-05-09 | $12.89 million | $0.01 | -$0.01 | 200% |
| 2001-01-31 | 2001-03-20 | $13 million | $0.02 | $0.04 | -50% |
| 2000-10-31 | 2000-12-31 | $13.78 million | -$0.08 | ||
| 2000-07-31 | 2000-08-10 | $13.66 million | -$0.02 | -$0.04 | 50% |
| 2000-04-30 | 2000-05-11 | $12.85 million | $0.02 | $0.02 | 0% |
| 2000-01-31 | 2000-03-29 | $14.14 million | $0.02 | $0.05 | -60% |
| 1999-07-31 | 1999-10-20 | $0.04 | $0.03 | 33.33% | |
| 1999-04-30 | 1999-07-22 | $0.05 | $0.04 | 25% | |
| 1999-01-31 | 1999-03-23 | $0.04 | $0.04 | 0% | |
| 1998-10-31 | 1998-11-13 | $0.03 | $0.13 | -76.92% | |
| 1998-07-31 | 1998-09-30 | -$0.10 | |||
| 1998-04-30 | 1998-07-29 | $0.11 | $0.13 | -15.38% | |
| 1998-01-31 | 1998-03-12 | $0.12 | $0.17 | -29.41% | |
| 1997-10-31 | 1997-11-05 | $0.15 | $0.15 | 0% | |
| 1997-07-31 | 1997-08-04 | $0.14 | $0.15 | -6.67% | |
| 1997-04-30 | 1997-05-07 | $0.13 | $0.14 | -7.14% | |
| 1997-01-31 | 1997-03-13 | $0.14 | $0.14 | 0% | |
| 1996-07-31 | 1996-10-30 | $0.13 | $0.13 | 0% | |
| 1996-04-30 | 1996-05-13 | $0.11 | $0.13 | -15.38% | |
| 1996-01-31 | 1996-03-31 | $0.14 | $0.20 | -30% | |
| 1995-04-30 | 1995-07-24 | $0.13 | $0.14 | -7.14% |
STAAR Surgical Company (STAA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
STAAR Surgical Company (STAA) Chart:
STAAR Surgical Company (STAA) News:
Below you will find a list of latest news for STAAR Surgical Company (STAA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
STAAR Surgical Company (STAA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-17 | 15 | 0 | CALL | 0 | 2 | 381.96 | TRUE | 0 | 0 |
| 2026-07-17 | 17.5 | 0 | CALL | 0 | 1 | 159.19 | TRUE | 0 | 0 |
| 2026-07-17 | 20 | 0 | CALL | 0 | 10 | 111.88 | TRUE | 0 | 0 |
| 2026-07-17 | 22.5 | 0 | CALL | 0 | 50 | 69.95 | TRUE | 0 | 0 |
| 2026-07-17 | 25 | 2.86 | CALL | 50 | 52 | 118.9 | TRUE | 2.86 | 0 |
| 2026-07-17 | 27.5 | 0.79 | CALL | 8 | 369 | 28.99 | TRUE | 0.09 | 0.13 |
| 2026-07-17 | 30 | 0.25 | CALL | 0 | 143 | 68.26 | FALSE | 0 | 0 |
| 2026-07-17 | 32.5 | 0 | CALL | 0 | 850 | 107.21 | FALSE | 0 | 0 |
| 2026-07-17 | 35 | 0.1 | CALL | 1 | 51 | 106.82 | FALSE | 0.1 | 0 |
| 2026-07-17 | 37.5 | 0 | CALL | 0 | 32 | 318.6 | FALSE | 0 | 0 |
| 2026-07-17 | 40 | 0 | CALL | 0 | 2 | 302.48 | FALSE | 0 | 0 |
| 2026-07-17 | 42.5 | 0 | CALL | 0 | 0 | 390.99 | FALSE | 0 | 0 |
| 2026-07-17 | 45 | 0 | CALL | 0 | 0 | 422.16 | FALSE | 0 | 0 |
| 2026-07-17 | 47.5 | 0 | CALL | 0 | 2 | 450.76 | FALSE | 0 | 0 |
| 2026-07-17 | 15 | 0 | PUT | 0 | 130 | 263.91 | FALSE | 0 | 0 |
| 2026-07-17 | 17.5 | 0 | PUT | 0 | 40 | 203.68 | FALSE | 0 | 0 |
| 2026-07-17 | 20 | 0 | PUT | 0 | 0 | 378.27 | FALSE | 0 | 0 |
| 2026-07-17 | 22.5 | 0 | PUT | 0 | 8 | 288.73 | FALSE | 0 | 0 |
| 2026-07-17 | 25 | 0 | PUT | 0 | 33 | 120.82 | FALSE | 0 | 0 |
| 2026-07-17 | 27.5 | 0 | PUT | 0 | 25 | 48.35 | FALSE | 0 | 0 |
| 2026-07-17 | 30 | 0 | PUT | 0 | 17 | 40.25 | TRUE | 0 | 0 |
| 2026-07-17 | 32.5 | 0 | PUT | 0 | 20 | 72.73 | TRUE | 0 | 0 |
| 2026-07-17 | 35 | 0 | PUT | 0 | 0 | 114.28 | TRUE | 0 | 0 |
| 2026-07-17 | 37.5 | 0 | PUT | 0 | 2 | 163.82 | TRUE | 0 | 0 |
| 2026-07-17 | 40 | 0 | PUT | 0 | 0 | 221.45 | TRUE | 0 | 0 |
| 2026-07-17 | 42.5 | 0 | PUT | 0 | 2 | 248.74 | TRUE | 0 | 0 |
| 2026-07-17 | 45 | 0 | PUT | 0 | 0 | 190.1 | TRUE | 0 | 0 |
| 2026-07-17 | 47.5 | 0 | PUT | 0 | 0 | 208.5 | TRUE | 0 | 0 |
| 2026-08-21 | 15 | 0 | CALL | 0 | 0 | 115.68 | TRUE | 0 | 0 |
| 2026-08-21 | 17.5 | 0 | CALL | 0 | 0 | 100.38 | TRUE | 0 | 0 |
| 2026-08-21 | 20 | 0 | CALL | 0 | 0 | 89.81 | TRUE | 0 | 0 |
| 2026-08-21 | 22.5 | 0 | CALL | 0 | 0 | 81.27 | TRUE | 0 | 0 |
| 2026-08-21 | 25 | 0 | CALL | 0 | 20 | 68.97 | TRUE | 0 | 0 |
| 2026-08-21 | 27.5 | 0 | CALL | 0 | 38 | 62.67 | TRUE | 0 | 0 |
| 2026-08-21 | 30 | 0 | CALL | 0 | 69 | 58.43 | FALSE | 0 | 0 |
| 2026-08-21 | 32.5 | 0 | CALL | 0 | 9 | 53.49 | FALSE | 0 | 0 |
| 2026-08-21 | 35 | 0 | CALL | 0 | 47 | 69 | FALSE | 0 | 0 |
| 2026-08-21 | 37.5 | 0 | CALL | 0 | 6 | 104.89 | FALSE | 0 | 0 |
| 2026-08-21 | 40 | 0 | CALL | 0 | 6 | 64.54 | FALSE | 0 | 0 |
| 2026-08-21 | 42.5 | 0 | CALL | 0 | 1 | 97.71 | FALSE | 0 | 0 |
| 2026-08-21 | 15 | 0.1 | PUT | 0 | 58 | 172.92 | FALSE | 0 | 0 |
| 2026-08-21 | 17.5 | 0 | PUT | 0 | 12 | 97.77 | FALSE | 0 | 0 |
| 2026-08-21 | 20 | 0 | PUT | 0 | 0 | 126.59 | FALSE | 0 | 0 |
| 2026-08-21 | 22.5 | 0 | PUT | 0 | 0 | 77.66 | FALSE | 0 | 0 |
| 2026-08-21 | 25 | 0 | PUT | 0 | 20 | 63.99 | FALSE | 0 | 0 |
| 2026-08-21 | 27.5 | 0 | PUT | 0 | 0 | 57.25 | FALSE | 0 | 0 |
| 2026-08-21 | 30 | 0 | PUT | 0 | 5 | 59.42 | TRUE | 0 | 0 |
| 2026-08-21 | 32.5 | 0 | PUT | 0 | 0 | 60.12 | TRUE | 0 | 0 |
| 2026-08-21 | 35 | 0 | PUT | 0 | 0 | 62.73 | TRUE | 0 | 0 |
| 2026-08-21 | 37.5 | 0 | PUT | 0 | 0 | 69.47 | TRUE | 0 | 0 |
| 2026-08-21 | 40 | 0 | PUT | 0 | 0 | 58.2 | TRUE | 0 | 0 |
| 2026-08-21 | 42.5 | 0 | PUT | 0 | 0 | 66.24 | TRUE | 0 | 0 |
| 2026-09-18 | 5 | 0 | CALL | 0 | 0 | 203.35 | TRUE | 0 | 0 |
| 2026-09-18 | 7.5 | 0 | CALL | 0 | 0 | 185.45 | TRUE | 0 | 0 |
| 2026-09-18 | 10 | 0 | CALL | 0 | 5 | 144.9 | TRUE | 0 | 0 |
| 2026-09-18 | 12.5 | 0 | CALL | 0 | 0 | 125.35 | TRUE | 0 | 0 |
| 2026-09-18 | 15 | 0 | CALL | 0 | 4 | 107.07 | TRUE | 0 | 0 |
| 2026-09-18 | 17.5 | 0 | CALL | 0 | 29 | 100.39 | TRUE | 0 | 0 |
| 2026-09-18 | 20 | 0 | CALL | 0 | 179 | 81.7 | TRUE | 0 | 0 |
| 2026-09-18 | 22.5 | 0 | CALL | 0 | 290 | 65.33 | TRUE | 0 | 0 |
| 2026-09-18 | 25 | 0 | CALL | 0 | 1033 | 62.69 | TRUE | 0 | 0 |
| 2026-09-18 | 27.5 | 0 | CALL | 0 | 181 | 63.08 | TRUE | 0 | 0 |
| 2026-09-18 | 30 | 0 | CALL | 0 | 846 | 58 | FALSE | 0 | 0 |
| 2026-09-18 | 32.5 | 0 | CALL | 0 | 48 | 61.71 | FALSE | 0 | 0 |
| 2026-09-18 | 35 | 0 | CALL | 0 | 490 | 65 | FALSE | 0 | 0 |
| 2026-09-18 | 37.5 | 0 | CALL | 0 | 9 | 69.77 | FALSE | 0 | 0 |
| 2026-09-18 | 40 | 0 | CALL | 0 | 403 | 73.07 | FALSE | 0 | 0 |
| 2026-09-18 | 42.5 | 0 | CALL | 0 | 1 | 97.59 | FALSE | 0 | 0 |
| 2026-09-18 | 45 | 0 | CALL | 0 | 0 | 104.58 | FALSE | 0 | 0 |
| 2026-09-18 | 47.5 | 0 | CALL | 0 | 1 | 110.1 | FALSE | 0 | 0 |
| 2026-09-18 | 5 | 0 | PUT | 0 | 11 | 258.25 | FALSE | 0 | 0 |
| 2026-09-18 | 7.5 | 0 | PUT | 0 | 76 | 130.88 | FALSE | 0 | 0 |
| 2026-09-18 | 10 | 0 | PUT | 0 | 45 | 103.45 | FALSE | 0 | 0 |
| 2026-09-18 | 12.5 | 0.1 | PUT | 0 | 178 | 101.58 | FALSE | 0 | 0 |
| 2026-09-18 | 15 | 0 | PUT | 0 | 18 | 149.05 | FALSE | 0 | 0 |
| 2026-09-18 | 17.5 | 0 | PUT | 0 | 93 | 121.44 | FALSE | 0 | 0 |
| 2026-09-18 | 20 | 0 | PUT | 0 | 16 | 98.83 | FALSE | 0 | 0 |
| 2026-09-18 | 22.5 | 0 | PUT | 0 | 26 | 63.04 | FALSE | 0 | 0 |
| 2026-09-18 | 25 | 0 | PUT | 0 | 101 | 56.32 | FALSE | 0 | 0 |
| 2026-09-18 | 27.5 | 2.5 | PUT | 0 | 76 | 67.98 | FALSE | 0 | 0 |
| 2026-09-18 | 30 | 0 | PUT | 0 | 99 | 59.28 | TRUE | 0 | 0 |
| 2026-09-18 | 32.5 | 0 | PUT | 0 | 14 | 56.09 | TRUE | 0 | 0 |
| 2026-09-18 | 35 | 0 | PUT | 0 | 39 | 62.03 | TRUE | 0 | 0 |
| 2026-09-18 | 37.5 | 0 | PUT | 0 | 0 | 57.37 | TRUE | 0 | 0 |
| 2026-09-18 | 40 | 0 | PUT | 0 | 0 | 55.13 | TRUE | 0 | 0 |
| 2026-09-18 | 42.5 | 0 | PUT | 0 | 0 | 54.46 | TRUE | 0 | 0 |
| 2026-09-18 | 45 | 0 | PUT | 0 | 0 | 60.49 | TRUE | 0 | 0 |
| 2026-09-18 | 47.5 | 0 | PUT | 0 | 0 | 66.14 | TRUE | 0 | 0 |
| 2026-12-18 | 7.5 | 0 | CALL | 0 | 1 | 138.77 | TRUE | 0 | 0 |
| 2026-12-18 | 10 | 0 | CALL | 0 | 42 | 111.16 | TRUE | 0 | 0 |
| 2026-12-18 | 12.5 | 0 | CALL | 0 | 3 | 95.48 | TRUE | 0 | 0 |
| 2026-12-18 | 15 | 0 | CALL | 0 | 5 | 83.55 | TRUE | 0 | 0 |
| 2026-12-18 | 17.5 | 0 | CALL | 0 | 62 | 74.93 | TRUE | 0 | 0 |
| 2026-12-18 | 20 | 0 | CALL | 0 | 117 | 72.16 | TRUE | 0 | 0 |
| 2026-12-18 | 22.5 | 0 | CALL | 0 | 341 | 70.86 | TRUE | 0 | 0 |
| 2026-12-18 | 25 | 5.83 | CALL | 0 | 757 | 69.56 | TRUE | 0 | 0 |
| 2026-12-18 | 27.5 | 5 | CALL | 0 | 307 | 67.6 | TRUE | 0 | 0 |
| 2026-12-18 | 30 | 0 | CALL | 0 | 351 | 65.21 | FALSE | 0 | 0 |
| 2026-12-18 | 32.5 | 3.05 | CALL | 3 | 335 | 61.8 | FALSE | 3.05 | 0 |
| 2026-12-18 | 35 | 0 | CALL | 0 | 374 | 58.78 | FALSE | 0 | 0 |
| 2026-12-18 | 37.5 | 0 | CALL | 0 | 37 | 59.49 | FALSE | 0 | 0 |
| 2026-12-18 | 40 | 0 | CALL | 0 | 501 | 56.18 | FALSE | 0 | 0 |
| 2026-12-18 | 42.5 | 0 | CALL | 0 | 0 | 62.66 | FALSE | 0 | 0 |
| 2026-12-18 | 45 | 0.75 | CALL | 3 | 7 | 62.19 | FALSE | 0.75 | 0 |
| 2026-12-18 | 47.5 | 0 | CALL | 0 | 40 | 75.74 | FALSE | 0 | 0 |
| 2026-12-18 | 7.5 | 0 | PUT | 0 | 0 | 146.97 | FALSE | 0 | 0 |
| 2026-12-18 | 10 | 0 | PUT | 0 | 78 | 146.98 | FALSE | 0 | 0 |
| 2026-12-18 | 12.5 | 0 | PUT | 0 | 709 | 78.19 | FALSE | 0 | 0 |
| 2026-12-18 | 15 | 0 | PUT | 0 | 102 | 67.04 | FALSE | 0 | 0 |
| 2026-12-18 | 17.5 | 0 | PUT | 0 | 294 | 70.91 | FALSE | 0 | 0 |
| 2026-12-18 | 20 | 0 | PUT | 0 | 90 | 63.16 | FALSE | 0 | 0 |
| 2026-12-18 | 22.5 | 0 | PUT | 0 | 15 | 63.42 | FALSE | 0 | 0 |
| 2026-12-18 | 25 | 0 | PUT | 0 | 64 | 58.97 | FALSE | 0 | 0 |
| 2026-12-18 | 27.5 | 0 | PUT | 0 | 122 | 57.58 | FALSE | 0 | 0 |
| 2026-12-18 | 30 | 0 | PUT | 0 | 310 | 58.59 | TRUE | 0 | 0 |
| 2026-12-18 | 32.5 | 0 | PUT | 0 | 13 | 56.7 | TRUE | 0 | 0 |
| 2026-12-18 | 35 | 0 | PUT | 0 | 81 | 53.37 | TRUE | 0 | 0 |
| 2026-12-18 | 37.5 | 0 | PUT | 0 | 0 | 51.74 | TRUE | 0 | 0 |
| 2026-12-18 | 40 | 0 | PUT | 0 | 3 | 58.27 | TRUE | 0 | 0 |
| 2026-12-18 | 42.5 | 0 | PUT | 0 | 0 | 56.68 | TRUE | 0 | 0 |
| 2026-12-18 | 45 | 0 | PUT | 0 | 0 | 59.26 | TRUE | 0 | 0 |
| 2026-12-18 | 47.5 | 0 | PUT | 0 | 0 | 50.17 | TRUE | 0 | 0 |
Latest STAA Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 10 | $62.72 |
| Jun 13, 2022 7:59 PM EST | 34 | $62.72 |
| Jun 13, 2022 7:59 PM EST | 46 | $62.73 |
| Jun 13, 2022 7:59 PM EST | 100 | $62.73 |
| Jun 13, 2022 7:59 PM EST | 54 | $62.73 |
STAAR Surgical Company (STAA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000091957420004440/0000919574-20-004440-index.htm |
| 2018-11-28 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/718937/000000000018036580/0000000000-18-036580-index.htm |
| 2018-12-20 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/718937/000000000018038870/0000000000-18-038870-index.htm |
| 2019-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/718937/000021545719005837/0000215457-19-005837-index.htm |
| 2020-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/718937/000083423720006928/0000834237-20-006928-index.htm |
| 2018-08-10 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/718937/000091957418005270/0000919574-18-005270-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000091957418006470/0000919574-18-006470-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000091957419003132/0000919574-19-003132-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000091957420000075/0000919574-20-000075-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000091957420004440/0000919574-20-004440-index.htm |
| 2020-08-12 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/718937/000091957420004985/0000919574-20-004985-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/718937/000093247119005805/0000932471-19-005805-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/718937/000110465920018279/0001104659-20-018279-index.htm |
| 2018-06-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420418034896/0001144204-18-034896-index.htm |
| 2018-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420418041360/0001144204-18-041360-index.htm |
| 2018-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/718937/000114420418041362/0001144204-18-041362-index.htm |
| 2018-08-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420418041608/0001144204-18-041608-index.htm |
| 2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420418042563/0001144204-18-042563-index.htm |
| 2018-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420418043427/0001144204-18-043427-index.htm |
| 2018-08-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420418045861/0001144204-18-045861-index.htm |
| 2018-09-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420418049318/0001144204-18-049318-index.htm |
| 2018-10-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420418056459/0001144204-18-056459-index.htm |
| 2018-10-31 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/718937/000114420418056465/0001144204-18-056465-index.htm |
| 2018-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420418056801/0001144204-18-056801-index.htm |
| 2018-11-02 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/718937/000114420418057028/0001144204-18-057028-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420418057442/0001144204-18-057442-index.htm |
| 2018-12-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/718937/000114420418064089/0001144204-18-064089-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420419000783/0001144204-19-000783-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420419000811/0001144204-19-000811-index.htm |
| 2019-01-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420419001931/0001144204-19-001931-index.htm |
| 2019-02-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420419009299/0001144204-19-009299-index.htm |
| 2019-02-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420419009509/0001144204-19-009509-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000114420419010801/0001144204-19-010801-index.htm |
| 2018-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919118037809/0001209191-18-037809-index.htm |
| 2018-06-14 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919118037925/0001209191-18-037925-index.htm |
| 2018-06-14 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919118037926/0001209191-18-037926-index.htm |
| 2018-06-15 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919118037928/0001209191-18-037928-index.htm |
| 2018-06-15 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919118037930/0001209191-18-037930-index.htm |
| 2018-06-15 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919118037932/0001209191-18-037932-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919118038342/0001209191-18-038342-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919118038343/0001209191-18-038343-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919118038345/0001209191-18-038345-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919118038346/0001209191-18-038346-index.htm |
| 2018-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919118047612/0001209191-18-047612-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119019673/0001209191-19-019673-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119019674/0001209191-19-019674-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119019677/0001209191-19-019677-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119019678/0001209191-19-019678-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119019679/0001209191-19-019679-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119020993/0001209191-19-020993-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119020995/0001209191-19-020995-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119020997/0001209191-19-020997-index.htm |
| 2019-03-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119020998/0001209191-19-020998-index.htm |
| 2019-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119023797/0001209191-19-023797-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119028213/0001209191-19-028213-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119038815/0001209191-19-038815-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119038816/0001209191-19-038816-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119038818/0001209191-19-038818-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119038819/0001209191-19-038819-index.htm |
| 2019-07-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119041749/0001209191-19-041749-index.htm |
| 2019-07-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119041750/0001209191-19-041750-index.htm |
| 2019-07-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119041753/0001209191-19-041753-index.htm |
| 2019-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119055495/0001209191-19-055495-index.htm |
| 2019-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119056718/0001209191-19-056718-index.htm |
| 2019-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119056725/0001209191-19-056725-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119057821/0001209191-19-057821-index.htm |
| 2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119058128/0001209191-19-058128-index.htm |
| 2019-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119059482/0001209191-19-059482-index.htm |
| 2019-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119059485/0001209191-19-059485-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919119060345/0001209191-19-060345-index.htm |
| 2020-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120004627/0001209191-20-004627-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120020257/0001209191-20-020257-index.htm |
| 2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120020910/0001209191-20-020910-index.htm |
| 2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120020913/0001209191-20-020913-index.htm |
| 2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120020915/0001209191-20-020915-index.htm |
| 2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120020917/0001209191-20-020917-index.htm |
| 2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120020922/0001209191-20-020922-index.htm |
| 2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120020924/0001209191-20-020924-index.htm |
| 2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120020928/0001209191-20-020928-index.htm |
| 2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120020930/0001209191-20-020930-index.htm |
| 2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120020932/0001209191-20-020932-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120028977/0001209191-20-028977-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120028979/0001209191-20-028979-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120028980/0001209191-20-028980-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120029842/0001209191-20-029842-index.htm |
| 2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120031993/0001209191-20-031993-index.htm |
| 2020-06-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120033941/0001209191-20-033941-index.htm |
| 2020-06-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120033945/0001209191-20-033945-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120033973/0001209191-20-033973-index.htm |
| 2020-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120033978/0001209191-20-033978-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120036240/0001209191-20-036240-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120037311/0001209191-20-037311-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120044682/0001209191-20-044682-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120044688/0001209191-20-044688-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120044693/0001209191-20-044693-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120044762/0001209191-20-044762-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120044768/0001209191-20-044768-index.htm |
| 2020-08-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120046447/0001209191-20-046447-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120046450/0001209191-20-046450-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120046451/0001209191-20-046451-index.htm |
| 2020-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120050130/0001209191-20-050130-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/718937/000120919120050755/0001209191-20-050755-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/718937/000130692320000009/0001306923-20-000009-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/718937/000142157819000010/0001421578-19-000010-index.htm |
| 2019-02-21 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/718937/000156459019003674/0001564590-19-003674-index.htm |
| 2019-04-15 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/718937/000156459019011633/0001564590-19-011633-index.htm |
| 2019-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/718937/000156459019013705/0001564590-19-013705-index.htm |
| 2019-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/718937/000156459019013718/0001564590-19-013718-index.htm |
| 2019-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019014821/0001564590-19-014821-index.htm |
| 2019-05-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/718937/000156459019014830/0001564590-19-014830-index.htm |
| 2019-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019015522/0001564590-19-015522-index.htm |
| 2019-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019015533/0001564590-19-015533-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019019269/0001564590-19-019269-index.htm |
| 2019-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019021717/0001564590-19-021717-index.htm |
| 2019-06-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019023002/0001564590-19-023002-index.htm |
| 2019-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019027490/0001564590-19-027490-index.htm |
| 2019-07-31 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/718937/000156459019027498/0001564590-19-027498-index.htm |
| 2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019027961/0001564590-19-027961-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019029687/0001564590-19-029687-index.htm |
| 2019-08-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019033050/0001564590-19-033050-index.htm |
| 2019-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019038781/0001564590-19-038781-index.htm |
| 2019-10-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/718937/000156459019038839/0001564590-19-038839-index.htm |
| 2019-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019039293/0001564590-19-039293-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019042037/0001564590-19-042037-index.htm |
| 2019-12-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019045698/0001564590-19-045698-index.htm |
| 2019-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459019046313/0001564590-19-046313-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020000921/0001564590-20-000921-index.htm |
| 2020-01-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020002809/0001564590-20-002809-index.htm |
| 2020-02-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020003112/0001564590-20-003112-index.htm |
| 2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020006783/0001564590-20-006783-index.htm |
| 2020-02-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/718937/000156459020006791/0001564590-20-006791-index.htm |
| 2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020007360/0001564590-20-007360-index.htm |
| 2020-04-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020016323/0001564590-20-016323-index.htm |
| 2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020020501/0001564590-20-020501-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020021915/0001564590-20-021915-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/718937/000156459020021932/0001564590-20-021932-index.htm |
| 2020-05-06 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/718937/000156459020021987/0001564590-20-021987-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020022838/0001564590-20-022838-index.htm |
| 2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020027750/0001564590-20-027750-index.htm |
| 2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020027955/0001564590-20-027955-index.htm |
| 2020-06-08 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/718937/000156459020028616/0001564590-20-028616-index.htm |
| 2020-06-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/718937/000156459020028621/0001564590-20-028621-index.htm |
| 2020-07-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020031771/0001564590-20-031771-index.htm |
| 2020-07-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020031892/0001564590-20-031892-index.htm |
| 2020-07-14 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/718937/000156459020032309/0001564590-20-032309-index.htm |
| 2020-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020035237/0001564590-20-035237-index.htm |
| 2020-08-04 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/718937/000156459020036115/0001564590-20-036115-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020036798/0001564590-20-036798-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/718937/000156459020036814/0001564590-20-036814-index.htm |
| 2020-08-06 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/718937/000156459020037718/0001564590-20-037718-index.htm |
| 2020-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020038023/0001564590-20-038023-index.htm |
| 2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020039124/0001564590-20-039124-index.htm |
| 2020-09-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020042255/0001564590-20-042255-index.htm |
| 2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020043353/0001564590-20-043353-index.htm |
| 2020-10-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020046039/0001564590-20-046039-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020050463/0001564590-20-050463-index.htm |
| 2020-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/718937/000156459020050470/0001564590-20-050470-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/718937/000156459020051424/0001564590-20-051424-index.htm |
| 2018-08-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/718937/000157104918000421/0001571049-18-000421-index.htm |
| 2018-08-09 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/718937/000157104918000428/0001571049-18-000428-index.htm |
STAAR Surgical Company (STAA) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of STAAR Surgical Company (STAA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 117%Institutional Ownership: 8992%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 20,000.00 | 7.52 | 150,400.00 | 101,185.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120031993/0001209191-20-031993-index.htm |
| 2020-01-21 | DEBORAH J ANDREWS | Chief Financial Officer | Buy | 9,000.00 | 7.36 | 66,240.00 | 106,101.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120004627/0001209191-20-004627-index.htm |
| 2020-03-23 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 2,813.00 | 26.83 | 75,472.79 | 10,794.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120020928/0001209191-20-020928-index.htm |
| 2020-05-11 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 46,563.00 | 39.11 | 1,821,078.93 | 10,794.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028980/0001209191-20-028980-index.htm |
| 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 41,602.00 | 51.22 | 2,130,854.44 | 10,794.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120046451/0001209191-20-046451-index.htm |
| 2019-05-03 | BROADWOOD PARTNERS, L.P. | 10% Share Holder | Buy | 0.00 | 10,840,630.00 | https://www.sec.gov/Archives/edgar/data/718937/000091957419003132/0000919574-19-003132-index.htm | ||
| 2019-05-03 | BROADWOOD PARTNERS, L.P. | 10% Share Holder | Buy | 100,000.00 | 22.23 | 2,223,000.00 | 10,840,630.00 | https://www.sec.gov/Archives/edgar/data/718937/000091957419003132/0000919574-19-003132-index.htm |
| 2019-11-14 | Scott D Barnes | Chief Medical Officer | Sell | 1,583.00 | 34.93 | 55,294.19 | 11,032.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119056718/0001209191-19-056718-index.htm |
| 2020-01-21 | DEBORAH J ANDREWS | Chief Financial Officer | Buy | 4,583.00 | 9.30 | 42,621.90 | 110,684.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120004627/0001209191-20-004627-index.htm |
| 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 21,875.00 | 9.30 | 203,437.50 | 123,060.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120031993/0001209191-20-031993-index.htm |
| 2019-12-04 | Hans-Martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 25,000.00 | 38.15 | 953,750.00 | 124,200.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119059482/0001209191-19-059482-index.htm |
| 2020-06-10 | Hans-Martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 785.00 | 44.00 | 34,540.00 | 127,950.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120036240/0001209191-20-036240-index.htm |
| 2020-06-15 | Hans-Martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Sell | 39,215.00 | 44.07 | 1,728,205.05 | 127,950.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120037311/0001209191-20-037311-index.htm |
| 2020-01-21 | DEBORAH J ANDREWS | Chief Financial Officer | Buy | 17,360.00 | 15.25 | 264,740.00 | 128,044.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120004627/0001209191-20-004627-index.htm |
| 2020-06-10 | Hans-Martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 785.00 | 11.00 | 8,635.00 | 128,735.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120036240/0001209191-20-036240-index.htm |
| 2020-01-21 | DEBORAH J ANDREWS | Chief Financial Officer | Buy | 7,291.00 | 16.15 | 117,749.65 | 135,335.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120004627/0001209191-20-004627-index.htm |
| 2020-03-20 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 7,357.00 | 13,607.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120020928/0001209191-20-020928-index.htm | ||
| 2019-06-20 | LOU SILVERMAN | Director | Buy | 2,127.00 | 13,733.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119038818/0001209191-19-038818-index.htm | ||
| 2020-01-21 | DEBORAH J ANDREWS | Chief Financial Officer | Buy | 3,370.00 | 29.80 | 100,426.00 | 138,705.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120004627/0001209191-20-004627-index.htm |
| 2019-11-05 | Keith Holliday | Chief Technology Officer | Sell | 14,441.00 | 35.00 | 505,435.00 | 14,323.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119055495/0001209191-19-055495-index.htm |
| 2019-12-04 | Hans-Martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 20,000.00 | 5.49 | 109,800.00 | 144,200.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119059482/0001209191-19-059482-index.htm |
| 2020-06-15 | Hans-Martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 19,215.00 | 11.00 | 211,365.00 | 147,165.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120037311/0001209191-20-037311-index.htm |
| 2019-12-04 | Hans-Martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 25,000.00 | 5.68 | 142,000.00 | 149,200.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119059482/0001209191-19-059482-index.htm |
| 2020-07-30 | LOU SILVERMAN | Director | Buy | 2,117.00 | 15,850.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120044768/0001209191-20-044768-index.htm | ||
| 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 3,437.00 | 39.02 | 134,111.74 | 16,022.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028977/0001209191-20-028977-index.htm |
| 2018-08-20 | William P Wall | Director | Sell | 5,000.00 | 41.35 | 206,750.00 | 16,235.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919118047612/0001209191-18-047612-index.htm |
| 2019-12-13 | William P Wall | Director | Sell | 4,000.00 | 37.40 | 149,600.00 | 16,489.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119060345/0001209191-19-060345-index.htm |
| 2020-06-15 | Hans-Martin Blickensdoerfer | Sr. VP, Comm. Ops, China | Buy | 20,000.00 | 5.34 | 106,800.00 | 167,165.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120037311/0001209191-20-037311-index.htm |
| 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 50,000.00 | 11.02 | 551,000.00 | 173,060.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120031993/0001209191-20-031993-index.htm |
| 2019-11-22 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 9,076.00 | 9.30 | 84,406.80 | 17,410.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119057821/0001209191-19-057821-index.htm |
| 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 20,000.00 | 11.02 | 220,400.00 | 193,060.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120031993/0001209191-20-031993-index.htm |
| 2020-09-14 | Keith Holliday | Chief Technology Officer | Sell | 9,115.00 | 53.49 | 487,561.35 | 19,332.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120050755/0001209191-20-050755-index.htm |
| 2020-09-15 | Keith Holliday | Chief Technology Officer | Sell | 36,326.00 | 53.33 | 1,937,265.58 | 19,332.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120050755/0001209191-20-050755-index.htm |
| 2020-03-23 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 2,813.00 | 27.42 | 77,132.46 | 19,459.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120020924/0001209191-20-020924-index.htm |
| 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 2,860.00 | 39.04 | 111,654.40 | 19,903.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028977/0001209191-20-028977-index.htm |
| 2020-03-20 | Scott D Barnes | Chief Medical Officer | Buy | 9,358.00 | 20,390.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120020913/0001209191-20-020913-index.htm | ||
| 2019-06-20 | William P Wall | Director | Buy | 4,254.00 | 20,489.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119038815/0001209191-19-038815-index.htm | ||
| 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 12,500.00 | 15.54 | 194,250.00 | 205,560.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120031993/0001209191-20-031993-index.htm |
| 2020-07-30 | John C Moore | Director | Buy | 2,117.00 | 2,117.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120044693/0001209191-20-044693-index.htm | ||
| 2020-07-30 | THOMAS G FRINZI | Director | Buy | 2,117.00 | 2,117.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120044682/0001209191-20-044682-index.htm | ||
| 2018-06-14 | William P Wall | Director | Buy | 3,691.00 | 21,235.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919118038343/0001209191-18-038343-index.htm | ||
| 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 3,473.00 | 39.02 | 135,516.46 | 21,292.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028977/0001209191-20-028977-index.htm |
| 2019-12-05 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 32,335.00 | 37.15 | 1,201,245.25 | 21,323.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119059485/0001209191-19-059485-index.htm |
| 2020-09-09 | John C Moore | Director | Sell | 137,331.00 | 52.04 | 7,146,705.24 | 21,387.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120050130/0001209191-20-050130-index.htm |
| 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 8,419.00 | 39.01 | 328,425.19 | 21,553.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028977/0001209191-20-028977-index.htm |
| 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 13,333.00 | 16.50 | 219,994.50 | 218,893.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120031993/0001209191-20-031993-index.htm |
| 2019-11-22 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 4,862.00 | 7.52 | 36,562.24 | 22,272.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119057821/0001209191-19-057821-index.htm |
| 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 6,292.00 | 29.80 | 187,501.60 | 225,185.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120031993/0001209191-20-031993-index.htm |
| 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 6,741.00 | 9.30 | 62,691.30 | 22,763.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028977/0001209191-20-028977-index.htm |
| 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 8,522.00 | 35.98 | 306,621.56 | 233,707.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120031993/0001209191-20-031993-index.htm |
| 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 4,862.00 | 15.25 | 74,145.50 | 24,765.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028977/0001209191-20-028977-index.htm |
| 2020-07-30 | Gilbert H Kliman | Director | Buy | 2,117.00 | 2,581.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120044688/0001209191-20-044688-index.htm | ||
| 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 16,206.00 | 9.30 | 150,715.80 | 27,000.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120046451/0001209191-20-046451-index.htm |
| 2020-03-20 | Keith Holliday | Chief Technology Officer | Buy | 7,874.00 | 28,447.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120020930/0001209191-20-020930-index.htm | ||
| 2020-05-15 | Keith Holliday | Chief Technology Officer | Sell | 25,000.00 | 37.69 | 942,250.00 | 28,447.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120029842/0001209191-20-029842-index.htm |
| 2020-09-14 | Keith Holliday | Chief Technology Officer | Sell | 26,574.00 | 53.26 | 1,415,331.24 | 28,447.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120050755/0001209191-20-050755-index.htm |
| 2019-11-04 | Keith Holliday | Chief Technology Officer | Sell | 2,100.00 | 35.00 | 73,500.00 | 28,764.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119055495/0001209191-19-055495-index.htm |
| 2020-09-14 | Keith Holliday | Chief Technology Officer | Buy | 1,286.00 | 7.52 | 9,670.72 | 29,733.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120050755/0001209191-20-050755-index.htm |
| 2020-05-11 | Graydon C. Hansen | Sr. VP, Global Operations | Buy | 8,680.00 | 16.15 | 140,182.00 | 29,972.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028977/0001209191-20-028977-index.htm |
| 2020-08-10 | Patrick F. Williams | Chief Financial Officer | Buy | 30,727.00 | 30,727.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120046450/0001209191-20-046450-index.htm | ||
| 2020-03-23 | DEBORAH J ANDREWS | Chief Financial Officer | Sell | 834.00 | 27.42 | 22,868.28 | 31,267.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120020910/0001209191-20-020910-index.htm |
| 2020-05-11 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 21,294.00 | 9.30 | 198,034.20 | 32,088.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028980/0001209191-20-028980-index.htm |
| 2019-11-14 | DEBORAH J ANDREWS | Chief Financial Officer | Sell | 4,167.00 | 34.68 | 144,511.56 | 32,101.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119056725/0001209191-19-056725-index.htm |
| 2020-01-21 | DEBORAH J ANDREWS | Chief Financial Officer | Sell | 106,604.00 | 42.20 | 4,498,688.80 | 32,101.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120004627/0001209191-20-004627-index.htm |
| 2020-09-15 | Keith Holliday | Chief Technology Officer | Buy | 13,217.00 | 16.15 | 213,454.55 | 32,549.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120050755/0001209191-20-050755-index.htm |
| 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 5,822.00 | 7.52 | 43,781.44 | 32,822.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120046451/0001209191-20-046451-index.htm |
| 2019-03-22 | Samuel J Gesten | Chief Legal Officer | Sell | 1,688.00 | 38.87 | 65,612.56 | 35,128.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119020995/0001209191-19-020995-index.htm |
| 2019-04-04 | DEBORAH J ANDREWS | Chief Financial Officer | Sell | 1,000.00 | 34.35 | 34,350.00 | 36,268.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119023797/0001209191-19-023797-index.htm |
| 2019-03-19 | Samuel J Gesten | Chief Legal Officer | Sell | 1,500.00 | 36.20 | 54,300.00 | 36,816.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119020995/0001209191-19-020995-index.htm |
| 2018-06-14 | STEPHEN C FARRELL | Director | Buy | 3,691.00 | 3,691.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919118038346/0001209191-18-038346-index.htm | ||
| 2019-03-22 | Keith Holliday | Chief Technology Officer | Sell | 3,125.00 | 38.89 | 121,531.25 | 37,114.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119020998/0001209191-19-020998-index.htm |
| 2019-03-22 | DEBORAH J ANDREWS | Chief Financial Officer | Sell | 833.00 | 38.88 | 32,387.04 | 37,268.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119020997/0001209191-19-020997-index.htm |
| 2018-06-14 | John C Moore | Director | Buy | 3,691.00 | 37,535.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919118038345/0001209191-18-038345-index.htm | ||
| 2019-03-19 | Keith Holliday | Chief Technology Officer | Sell | 2,084.00 | 36.22 | 75,482.48 | 40,239.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119020998/0001209191-19-020998-index.htm |
| 2020-03-23 | Samuel J Gesten | Chief Legal Officer | Sell | 2,742.00 | 27.42 | 75,185.64 | 41,185.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120020922/0001209191-20-020922-index.htm |
| 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Sell | 192,522.00 | 40.00 | 7,700,880.00 | 41,185.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120031993/0001209191-20-031993-index.htm |
| 2020-09-15 | Keith Holliday | Chief Technology Officer | Buy | 10,112.00 | 29.80 | 301,337.60 | 42,661.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120050755/0001209191-20-050755-index.htm |
| 2020-03-20 | Samuel J Gesten | Chief Legal Officer | Buy | 7,745.00 | 42,873.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120020922/0001209191-20-020922-index.htm | ||
| 2019-03-19 | Caren L Mason | President & CEO | Sell | 7,500.00 | 36.25 | 271,875.00 | 44,013.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119020993/0001209191-19-020993-index.htm |
| 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 11,574.00 | 8.64 | 99,999.36 | 44,396.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120046451/0001209191-20-046451-index.htm |
| 2020-03-23 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Sell | 2,250.00 | 26.77 | 60,232.50 | 44,466.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120020917/0001209191-20-020917-index.htm |
| 2020-05-11 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Sell | 18,856.00 | 39.06 | 736,515.36 | 44,466.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028979/0001209191-20-028979-index.htm |
| 2019-05-06 | John C Moore | Director | Buy | 7,500.00 | 1.92 | 14,400.00 | 45,035.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119028213/0001209191-19-028213-index.htm |
| 2020-06-01 | Gilbert H Kliman | Director | Buy | 464.00 | 464.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120033978/0001209191-20-033978-index.htm | ||
| 2020-03-20 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 6,913.00 | 46,716.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120020917/0001209191-20-020917-index.htm | ||
| 2019-06-20 | John C Moore | Director | Buy | 4,254.00 | 49,289.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119038816/0001209191-19-038816-index.htm | ||
| 2020-09-14 | Keith Holliday | Chief Technology Officer | Buy | 21,294.00 | 9.30 | 198,034.20 | 51,027.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120050755/0001209191-20-050755-index.htm |
| 2020-05-13 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 6,667.00 | 5.34 | 35,601.78 | 51,133.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028979/0001209191-20-028979-index.htm |
| 2020-05-11 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 19,178.00 | 7.52 | 144,218.56 | 51,266.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028980/0001209191-20-028980-index.htm |
| 2020-01-21 | DEBORAH J ANDREWS | Chief Financial Officer | Buy | 20,000.00 | 11.00 | 220,000.00 | 52,101.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120004627/0001209191-20-004627-index.htm |
| 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 8,000.00 | 16.15 | 129,200.00 | 52,396.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120046451/0001209191-20-046451-index.htm |
| 2020-05-11 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 8,000.00 | 7.35 | 58,800.00 | 52,466.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028979/0001209191-20-028979-index.htm |
| 2020-05-15 | Keith Holliday | Chief Technology Officer | Buy | 25,000.00 | 7.20 | 180,000.00 | 53,447.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120029842/0001209191-20-029842-index.htm |
| 2019-12-05 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 32,335.00 | 8.64 | 279,374.40 | 53,658.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119059485/0001209191-19-059485-index.htm |
| 2020-09-14 | Keith Holliday | Chief Technology Officer | Buy | 3,994.00 | 16.15 | 64,503.10 | 55,021.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120050755/0001209191-20-050755-index.htm |
| 2020-09-15 | Keith Holliday | Chief Technology Officer | Buy | 12,997.00 | 35.98 | 467,632.06 | 55,658.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120050755/0001209191-20-050755-index.htm |
| 2019-11-25 | John C Moore | Director | Sell | 8,613.00 | 38.54 | 331,945.02 | 56,422.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119058128/0001209191-19-058128-index.htm |
| 2020-05-11 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 6,091.00 | 8.64 | 52,626.24 | 57,357.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028980/0001209191-20-028980-index.htm |
| 2020-07-30 | STEPHEN C FARRELL | Director | Buy | 2,117.00 | 5,808.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120044762/0001209191-20-044762-index.htm | ||
| 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 20,000.00 | 5.34 | 106,800.00 | 61,185.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120031993/0001209191-20-031993-index.htm |
| 2019-12-05 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 15,073.00 | 37.31 | 562,373.63 | 6,250.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119059485/0001209191-19-059485-index.htm |
| 2020-05-11 | James E Francese | Sr. VP, Comm. Ops., NA, APAC | Buy | 10,856.00 | 15.54 | 168,702.24 | 63,322.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120028979/0001209191-20-028979-index.htm |
| 2019-11-25 | John C Moore | Director | Buy | 20,000.00 | 4.73 | 94,600.00 | 65,035.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119058128/0001209191-19-058128-index.htm |
| 2020-03-18 | John C Moore | Director | Buy | 10,000.00 | 5.81 | 58,100.00 | 66,422.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120020257/0001209191-20-020257-index.htm |
| 2020-01-21 | DEBORAH J ANDREWS | Chief Financial Officer | Buy | 20,000.00 | 5.34 | 106,800.00 | 72,101.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120004627/0001209191-20-004627-index.htm |
| 2020-05-21 | Samuel J Gesten | Chief Legal Officer | Buy | 20,000.00 | 7.35 | 147,000.00 | 81,185.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120031993/0001209191-20-031993-index.htm |
| 2020-01-21 | DEBORAH J ANDREWS | Chief Financial Officer | Buy | 10,000.00 | 15.54 | 155,400.00 | 82,101.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120004627/0001209191-20-004627-index.htm |
| 2019-11-20 | Graydon C. Hansen | Sr. VP, Global Operations | Sell | 17,083.00 | 35.02 | 598,246.66 | 8,334.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919119057821/0001209191-19-057821-index.htm |
| 2020-01-21 | DEBORAH J ANDREWS | Chief Financial Officer | Buy | 15,000.00 | 7.35 | 110,250.00 | 97,101.00 | https://www.sec.gov/Archives/edgar/data/718937/000120919120004627/0001209191-20-004627-index.htm |